Loading...
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
The benzothiazinone lead compound, BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1, decaprenylphosphoryl-beta-D-ribose 2-epimerase. Here, we synthesized a new series of piperazine-containing benzothiazinones (PBTZ) and show that, like BTZ043, the preclinical c...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958311/ https://ncbi.nlm.nih.gov/pubmed/24500695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201303575 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|